Sensei Biotherapeutics is developing an innovative pipeline of first-in-class immune activating agents for a broad array of cancers including solid tumors and hematological malignancies. Our therapies benefit from a precision medicine approach that has the potential to identify patients that will be... Read more
Kyverna Therapeutics
7 followers
Tyra Biosciences
1 follower
Galatea Bio
13 followers
School District of Philadelphia
5 followers
DECA
4 followers
Discovery Life Sciences
3 followers
Mineralys Therapeutics
3 followers
Mirum Pharmaceuticals
9 followers
James Madison University
2 followers
Candel Therapeutics
2 followers
23andMe
91 followers
Tempus Labs
33 followers